Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Clinical trial NCT02104804 · COMPLETED
Trial details
- NCT number
- NCT02104804
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-07
- Primary completion
- 2016-02-26
- Enrollment
- 953
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.